Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 623 results found. Search for [ coronavirus vaccine developed in India ]

Results 200 to 220 of 623
Joe C Mathew
November 21, 2020
\"We expect emergency authorisation for Oxford-Astrazeneca vaccine to be sought in the UK. If so, it will give an opportunity for India regulator also (to consider such an option),\" says Dr Vinod Paul, chairman of the National Expert Group on Vaccine Administration for COVID-19


BusinessToday.In
November 21, 2020
Bharat Biotech, the developer of India's indigenous vaccine Covaxin, has said that it is planning to enrol about 2,000 participants each in metros for Phase-3 trials of its COVID-19 vaccine that began earlier this week


BusinessToday.In
November 21, 2020
Pfizer's CEO Albert Bourla confirmed the company's application and said in a video statement,  'It is with great pride and joy - and even a little relief - that I can say that our request for emergency use authorization for our COVID-19 vaccine is now in the FDA's hands.'


BusinessToday.In
New Delhi, November 19, 2020
A fast and cheap coronavirus testing kit that can provide results in 40 minutes was launched in Delhi on Thursday. The indigenously developed testing kit for coronavirus based on the gene-editing technology CRISPR called Feluda was launched by Tata group in collaboration with the Apollo group of hospitals. The test is likely to be cheaper than the current gold standard RT-PCR and equally accurate, helping in scaling up COVID-19 testing. Watch the video for more.Also Read: Pfizer share rises nearly 7% after firm says COVID-19 vaccine 95% effective


BusinessToday.In
November 19, 2020
Union Health Minister Harsh Wardhan asserted that India has managed despite facing scarcities of PPE kits, ventilators and N-95 masks at the start of the pandemic and is now leading the research on the vaccine globally


BusinessToday.In
November 19, 2020
Late-stage trials of the Oxford vaccine are still awaited but hopes are high that it'll also join frontrunners' league with Pfizer, Moderna and Russia's Sputnik V


BusinessToday.In
November 18, 2020
Narayana Murthy appealed to companies who can afford to bear the cost to give the vaccines for free. He also said that UN Security Council members should share a major part of this cos


BusinessToday.In
November 17, 2020
Moderna had announced on November 16 that after Phase 3 of trials their COVID-19 vaccine candidate was 94.5% effective in preventing coronavirus infection


BusinessToday.In
November 17, 2020
Moderna had announced on November 16 that after Phase 3 of trials their COVID-19 vaccine candidate was 94.5% effective in preventing coronavirus infection


BusinessToday.In
November 17, 2020
Moderna had announced on November 16 that after Phase 3 of trials their COVID-19 vaccine candidate was 94.5% effective in preventing coronavirus infection


Reuters
November 17, 2020
The Hyderabad-based firm initiated phase I and phase II trials of its vaccine candidate after getting the green signal from the Drugs Controller General of India


BusinessToday.In
November 16, 2020
Moderna stated that its COVID-19 vaccine candidate remains stable for 30 days at 2-degree Celsius to 8-degree Celsius, the temperature of a standard home or medical refrigerator


PTI
November 16, 2020
Speaking virtually at a programme organised by the Indian School of Business, Ella said the company is also working on another vaccine for COVID-19 which would be in the form of nasal drops and can be ready by next year


Aseem Thapliyal
November 15, 2020
Over the past week, the 30-share BSE Sensex jumped 1,744.92 points or 4.16 per cent


PTI
November 15, 2020
The Coastal Shipping Bill, 2020, which proposes to do away with the requirement of trading licence for Indian flag vessels for coastal trade has been circulated for inter-ministerial consultation


BusinessToday.In
November 15, 2020
As per Anthony Fauchi, the Pfizer's vaccine distribution process in the US will start in December. This, he said, will also help reduce the daily spike in coronavirus cases, which reached 1.9 lakh this week


BusinessToday.In
November 12, 2020
US-based Moderna Inc has claimed that it has sufficient data for a first interim analysis of the advanced-phase trial of its COVID-19 vaccine candidate, which should help ascertain the inoculation's efficacy


Anwesha Madhukalya
November 12, 2020
Nirmala Sitharaman press conference: The minister said that the Rs 900 crore funding to the Department of Biotechnology will be for research purposes only


BusinessToday.In
November 12, 2020
Pfizer COVID-19 vaccine would need to be stored at -70 degree Celsius, which experts believe, would be a daunting challenge even for the best medical centres


BusinessToday.In
November 11, 2020
Russia coronavirus vaccine: The interim trial results were announced by Russia's sovereign wealth fund Russian Direct Investment Fund on Wednesday. RDIF is backing the vaccine and marketing it globally


PAGES 11 OF 32  1112131415